Nose-to-brain drug delivery: A new frontier in targeted therapeutics
Delivering therapeutics to the Central Nervous System (CNS) remains a major challenge in drug development, largely because the blood–brain barrier (BBB) limits brain exposure for most systemically administered agents. Among alternative delivery routes, intranasal administration has attracted significant interest becaus...